Abstract
Robert B. Kargbo, Alexander Sherwood, Nicholas V. Cozzi, Raymond E. Dagger, Jessica Sable, Kelsey O’Hern, Kristi Kaylo, Tura Patterson, Gary Tarpley, Poncho Meisenheimer
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Novel Psychotherapeutics - A Cautiously Optimistic Focus on Hallucinogens
10.1080/17512433.2018.1415755 · 2018
Potential therapeutic effects of psilocybin
10.1007/s13311-017-0542-y · 2017
Psilocybin With Psychological Support For Treatment-Resistant Depression: An Open-Label Feasibility Study
10.1016/s2215-0366(16)30065-7 · 2016
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
10.1177/0269881116675513 · 2016
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
10.1177/0269881116675512 · 2016
Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer
10.1001/archgenpsychiatry.2010.116 · 2011
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
10.4088/jcp.v67n1110 · 2006
Long-term follow-up of psilocybin-facilitated smoking cessation
10.3109/00952990.2016.1170135 · 2017
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
10.1177/0269881114548296 · 2014
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
10.1177/0269881119897615 · 2020
Unresolved referenced work
1991
Unresolved referenced work
1997
Hallucinogens
10.1016/j.pharmthera.2003.11.002 · 2004
Psychedelics
10.1124/pr.115.011478 · 2016
The oldest representations of hallucinogenic mushrooms in the world (Sahara Desert, 9000-7000 BP)
1992
Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults
10.1007/s40262-017-0540-6 · 2017
Abwandlungsprodukte von Psilocybin und Psilocin. 2. Mitteilung über synthetische Indolverbindungen
10.1002/hlca.19590420638 · 1959
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
An Improved, Practical, and Scalable Five-Step Synthesis of Psilocybin
10.1055/s-0039-1691565 · 2020
Concise Large-Scale Synthesis of Psilocin and Psilocybin, Principal Hallucinogenic Constituents of “Magic Mushroom”
10.1021/np030059u · 2003
Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin
10.1055/s-1999-3490 · 1999
Injury-Triggered Blueing Reactions of Psilocybe ″Magic″ Mushrooms
10.1002/anie.201910175 · 2020
Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin
10.1021/acs.jnatprod.9b01061 · 2020
Unresolved referenced work
1967
Dissociation Constants of Substituted Ethylenediamines
10.1021/ja01102a507 · 1953
The reduction of acid amides with lithium aluminum hydride
10.1021/jo50015a017 · 1953
Synthesis And Biological Evaluation Of Deuterated Sofosbuvir Analogs As Hcv Ns5B Inhibitors With Enhanced Pharmacokinetic Properties
10.1002/jlcr.3715 · 2019
Aryl phosphoramidates of 5-phospho erythronohydroxamic acid, a new class of potent trypanocidal compounds
10.1021/jm1004754 · 2010
A metathesis route for BODIPY labeled polyolefins
10.1021/ol401461h · 2013
Diethyl phosphorocyanidate (DEPC): a versatile reagent for organic synthesis
10.1016/j.tet.2016.09.070 · 2016
Exploration Of Chiral Lewis Acid Mg2+ Catalysts In The Synthesis Of Aryl Organophosphate Triesters From Phosphorus Oxychloride Through A Three-Step, Two-Pot Substitution Sequence
10.1016/j.tetlet.2018.02.066 · 2018
Selected Methods for the Chemical Phosphorylation and Thiophosphorylation of Phenols
10.1002/ajoc.201700638 · 2018
Evolution of a Scale-Up Synthesis to a Potent GluN2B Inhibitor and Its Prodrug
10.1021/acs.oprd.8b00120 · 2018
Unresolved referenced work
Kept as external metadata until matched
Crystal structures of the Teonanácatl hallucinogens. Part I. Psilocybin C12H17N2O4P
10.1039/p29740000942 · 1974
X-Ray Powder Diffraction Data For Some Drugs, Excipients, And Adulterants In Illicit Samples
10.1520/jfs10282j · 1975
Unresolved referenced work
Kept as external metadata until matched
No additional external references are available.